Used primarily in research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is valuable in studying neurological and psychiatric disorders. It helps modulate intracellular signaling pathways involved in dopamine regulation, making it a tool compound for investigating conditions such as schizophrenia, Huntington’s disease, and other disorders linked to basal ganglia dysfunction. Due to its ability to cross the blood-brain barrier and exhibit high target specificity, it is employed in preclinical studies to evaluate the therapeutic potential of PDE10A inhibition. Its structure supports strong binding affinity and metabolic stability, which are advantageous for in vivo experiments.